ALTEOGEN Inc Cash Flow-to-Debt Ratio
ALTEOGEN Inc cash flow-to-debt ratio. ALTEOGEN Inc (196170) has a Cash Flow-to-Debt Ratio of 0.09x as of June 2026, meaning its operating cash flow of ₩16.56 Billion could theoretically repay 0% of its total liabilities (₩192.66 Billion) in one year. Check ALTEOGEN Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ALTEOGEN Inc (2014–2025)
Cash flow-to-debt ratio of ALTEOGEN Inc from 2014 to 2025. Historical debt coverage capacity for ALTEOGEN Inc across 12 annual periods. Check ALTEOGEN Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
ALTEOGEN Inc Cash Flow-to-Debt Ratio by Year (2014–2025)
ALTEOGEN Inc cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for ALTEOGEN Inc. For the full cash flow conversion analysis, see ALTEOGEN Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.51x | ₩124.13 Billion | ₩244.30 Billion | ▲ +29.2% |
| 2024 | 0.39x | ₩53.04 Billion | ₩134.92 Billion | ▲ +648.1% |
| 2023 | -0.07x | ₩-7.77 Billion | ₩108.26 Billion | ▲ +61.2% |
| 2022 | -0.18x | ₩-17.87 Billion | ₩96.73 Billion | ▼ -141.4% |
| 2021 | -0.08x | ₩-9.46 Billion | ₩123.61 Billion | ▼ -241.9% |
| 2020 | 0.05x | ₩1.51 Billion | ₩28.04 Billion | ▼ -90.6% |
| 2019 | 0.57x | ₩9.13 Billion | ₩16.00 Billion | ▲ +129.8% |
| 2018 | -1.92x | ₩-9.11 Billion | ₩4.76 Billion | ▼ -39.7% |
| 2017 | -1.37x | ₩-4.35 Billion | ₩3.17 Billion | ▼ -18.2% |
| 2016 | -1.16x | ₩-3.16 Billion | ₩2.72 Billion | ▼ -142.8% |
| 2015 | 2.71x | ₩2.26 Billion | ₩834.62 Million | ▲ +378.3% |
| 2014 | 0.57x | ₩1.21 Billion | ₩2.13 Billion | — |